期刊文献+

TRAF6-GST融合蛋白在大肠杆菌中的表达及纯化 被引量:2

Expression in Escherichia coli and Purification of GST tag TRAF6
下载PDF
导出
摘要 目的:在大肠杆菌中表达肿瘤坏死因子受体相关因子6(TRAF6)与GST的融合蛋白并进行纯化。方法:采用PCR方法从肝文库中扩增编码TRAF6的DNA片段,将其插入原核表达载体pGEX-4T-2,构建GST-TRAF6原核表达载体,并转入大肠杆菌BL21(DE3)中,用IPTG诱导表达;用谷胱甘肽-琼脂糖珠亲和纯化表达的GST-TRAF6融合蛋白。结果:酶切鉴定和测序分析显示,长为1569 bp的TRAF6 DNA片段在pGEX-4T-2-TRAF6中的碱基序列、插入位点及读框正确,且位于表达载体的GST序列下游;经IPTG最佳浓度0.5 mmol/L诱导表达、亲和纯化后,获得了相对分子质量约85×103的GST-TRAF6融合蛋白。结论:构建了重组GST-TRAF6原核表达载体,获得了GST-TRAF6的大肠杆菌BL21表达菌株及GST-TRAF6融合蛋白,利于深入研究TRAF6的功能。 Objective: To express tumor necrosis factor receptor associated factor-6(TRAF6) fused with GST tag in E.coli BL21(DE3) and to purify it.Methods: The gene of TRAF-6 was amplified from liver gene library by PCR method,and was inserted into prokaryotic expression plasmid pGEX-4T-2 to construct prokaryotic expression vector of GST-TRAF6.Induced by IPTG,the recombinant GST-TRAF6 was expressed.At last,we purified recom-binant protein of GST-TRAF6 with glutathione-agarose beans.Results: Recombinant expression plasmid of GST-TRAF6 with the TRAF6 DNA fragment length of 1569 bp was confirmed by restriction enzyme digestion and se-quencing.The optimal IPTG concentration was 0.5 mmol / L determined by pretest.TRAF6 was downstream of GST gene,so we could obtain TRAF6 protein about 85 kD by affinity purification.Conclusion: Recombinant prokaryotic expression vector of GST-TRAF6 was correctly constructed,and the purified recombinant protein of GST-TRAF6 was obtained.
出处 《生物技术通讯》 CAS 2011年第5期679-682,共4页 Letters in Biotechnology
基金 国家重点基础研究发展计划(2011CB910600)
关键词 肿瘤坏死因子受体相关因子6 原核表达 蛋白纯化 tumor necrosis factor receptor associated factor-6 prokaryotic expression protein purification
  • 相关文献

参考文献11

  • 1Bradley J R,Pober J S.Tumor necrosis factor receptor-associated factors(TRAFs)[J].Oncogene,2001,20(44):6482-6491.
  • 2Mercier P,Lewis M J,Hau D D,et al.Structure,interactions,and dynamics of the RING domain from human TRAF6[J].Protein Sci,2007,16(4):602-614.
  • 3Ma T,Wang N,Su Z,et al.Characterization of apoptosis and proliferation in esophageal carcinoma EC109 cells following siRNA-induced down-regulation of TRAF6[J].Mol Cell Biochem,2011,352(1-2):77-85.
  • 4Jeong S,Cho I R,An W G,et al.STP-A11,an oncoprotein of Herpesvirus saimiri augments both NF-kappaB and AP-1 transcription activity through TRAF6[J].Exp Mol Med,2007,39(6):56-64.
  • 5Hirayama T,Tamaki Y,Takakubo Y,et al.Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles[J].J Orthopaedic Res,2011,29(5):21361-21369.
  • 6Arcipowski K M,Stunz L L,Graham J P,et al.Molecular mechanisms of TNFR-associated factor 6(TRAF6) utilization by the oncogenic viral mimic of CD40,latent membrane protein 1 (LMP1)[J].J Biol Chem,2011,286(12):9948-9955.
  • 7Rowland S L,Tremblay M M,Ellison J M,et al.A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling[J].J Immunol,2007,179(7):4645-4653.
  • 8Megas C,Hatzivassiliou E G,Yin Q,et al.Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation[J].Cell Signal,2010,23(5):772-777.
  • 9Gautheron J,Pescatore A,Fusco F,et al.Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology[J].Hum Mol Gene,2010,19(16):3138-3149.
  • 10Damay B G,Ni J,Moore P A,et al.Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor(TRAF) 6 and NF-kappaB-inducing kinase[J].J Biol Chem,1999,274(12):7724-7731.

同被引文献20

  • 1WANG YaYa1,ZHANG Peng2,LIU YingFang2 & CHENG GenHong1 1 Department of Microbiology,Immunology & Molecular Genetics,University of California Los Angeles,609 Charles E.Young Drive East,Los Angeles,California 90095,USA,2 National Laboratory of Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China.TRAF-mediated regulation of immune and inflammatory responses[J].Science China(Life Sciences),2010,53(2):159-168. 被引量:21
  • 2张少恩,孙晗笑,张光,杨清玲,沙文琼,刘俊云,龚莉桂.大肠杆菌表达的vMIP-Ⅱ包涵体的纯化与复性研究[J].中国生物制品学杂志,2005,18(3):247-251. 被引量:10
  • 3白东亭,许丽锋.重组大肠杆菌的包涵体[J].中国生物制品学杂志,1996,9(4):188-191. 被引量:16
  • 4罗惠霞,李敏,王玉炯.包涵体蛋白复性的几种方法[J].生物技术通报,2007,23(5):96-98. 被引量:25
  • 5李校垫,袁辉.药物蛋白质分离纯化技术[M].北京:化学工业出版社,2005.
  • 6Muzio M, Natoli G, Saccani S, et al. The human toll signaling pathway : divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) [J]. J Exp Med, 1998, 187 (12) : 2097-2101.
  • 7Rauta PR, Samanta M, Dash HR, et al. Tollqike receptors ( TLRs ) in aquatic animals : Signaling pathways, expressions and immune responses [ J ] . Immunol Lett, 2013, 158 ( 1-2 ) : 14-24.
  • 8Xie P. TRAF molecules in cell signaling and in human diseases [ J ]. J Mol Signal, 2013, 8 : 7.
  • 9Chapard C, Hohl D, Huber M. The role of the TRAF-interacting protein in proliferation and differentiation [ J ] . Exp Dermatol, 2012, 21 ( 5 ) : 321-326.
  • 10Lin XW, Xu WC, Luo JG, et al. WW domain containing E3 ubiquitin protein ligase 1 ( WWP1 ) negatively regulates TLR4-mediated TNF-et and I1,-6 production by proteasomal degradation of TNF receptor associated factor 6 ( TRAF6 )[ J ]. PLoS One, 2013, 8 ( 6 ): e67633.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部